Pharmaceuticals, Biotechnology and Life Sciences
Vertex got a deal with NHS England, to enable eligible patients with cystic fibrosis in England the access to Orkambi…
Syros’s SY-1425 plus Azacitidine testing data showed 62% composite complete response rate, with 82% of patients achieving or maintaining transfusion…
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…
Tilray has imported medical cannabis to USA and Canada in support of a new trieal, first-of-its-kind, which will test the…
Baxter reported that in third quarter it got net revenue of $2.85 billion, which increased 3% on a reported basis…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has granted…
Rocket Pharmaceuticals said that two critical validations for an FA gene therapy product are: 1) stem cell engraftment in the…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), has completed patient enrollment in its Phase 2 clinical trial of AR-1105 in…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced sales for the third quarter…
Expanded indication allows for treatment of women whose advanced ovarian cancer is associated with homologous recombination deficiency (HRD) Zejula is…